Literature DB >> 18524468

Management of advanced prostate cancer: gonadotropin-releasing hormone blockers might improve prognosis.

Axel Heidenreich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18524468     DOI： 10.1016/j.eururo.2008.04.101

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

Review 1.  Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks.

Authors:  Hendrik Isbarn; Laurent Boccon-Gibod; Peter R Carroll; Francesco Montorsi; Claude Schulman; Matthew R Smith; Cora N Sternberg; Urs E Studer
Journal:  Eur Urol       Date:  2008-10-14       Impact factor: 20.096

2.  Degarelix for the treatment of advanced prostate cancer compared with GnRh-Agonists: a systematic review and meta-analysis.

Authors:  Seyed Alireza Hosseini; Fatemeh Rajabi; Ali Akbari Sari; Mohsen Ayati; Saeed Heidari; Fawzieh Ghamary
Journal:  Med J Islam Repub Iran       Date:  2016-01-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.